The Mayo Clinic, the leading US hospital, will test Nevisense in Pilot

"We are proud to work with the Mayo Clinic and believe this pilot represents an opportunity for SciBase to continue to address an unmet medical need by expanding access of the Nevisense test to more US patients at-point-of-care, when it is critical and makes a profound impact on patient care," said Pia Renaudin, CEO of SciBase. "We are proud to work with the Mayo Clinic and believe this pilot represents an opportunity for SciBase to continue to address an unmet medical need by expanding access...

STOCKHOLM, 03/01/2025 (informazione.news - comunicati stampa - salute e benessere)

"We are proud to work with the Mayo Clinic and believe this pilot represents an opportunity for SciBase to continue to address an unmet medical need by expanding access of the Nevisense test to more US patients at-point-of-care, when it is critical and makes a profound impact on patient care," said Pia Renaudin, CEO of SciBase.

Pia Renaudin , CEO, tel. +46732069802, e-mail: pia.renaudin@scibase.com

Carnegie Investment Bank AB (publ)
Phone: +46 (0)73 856 42 65
E-mail: certifiedadviser@carnegie.se

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/scibase/r/the-mayo-clinic--the-leading-us-hospital--will-test-nevisense-in-pilot,c4087586

The following files are available for download:

 

View original content:https://www.prnewswire.co.uk/news-releases/the-mayo-clinic-the-leading-us-hospital-will-test-nevisense-in-pilot-302341737.html